<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02546557</url>
  </required_header>
  <id_info>
    <org_study_id>AAG-O-H-1421</org_study_id>
    <nct_id>NCT02546557</nct_id>
  </id_info>
  <brief_title>Optilene® Suture for Coronary Artery Bypass Graft Surgery</brief_title>
  <acronym>OPTICABG</acronym>
  <official_title>Assessment of the Performance of a New Suture Material (Optilene® Suture) for Coronary Artery Bypass Graft Surgery. An Observational Post CE-mark Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aesculap AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>B.Braun Surgical SA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Aesculap AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a voluntary study, initiated by B. Braun to collect clinical data for Optilene®
      suture concerning its key indication.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coronary artery bypass graft (CABG) surgery is one of the most common elective surgical
      procedure. In total 40.000 CABG´s have been performed yearly in Germany in 2012 and 2013
      which presents 60% of all cardiac surgical interventions. Coronary artery bypass grafting is
      performed for patients with coronary artery disease (CAD) to improve quality of life and to
      reduce cardiac-related mortality. CAD is the most leading cause of mortality in the Western
      world as well as in developing countries and it is the most common cause of heart failure.
      CABG was introduced in the 1960s. CABG operation has become the most studied intervention in
      the history of surgery. It is highly effective in the treatment of severe angina and it
      delays unfavorable events such as death, myocardial infarction and recurrence of angina in
      comparison to other treatment forms. There is a general agreement that already in the early
      postoperative period CABG surgery improves the disease in patients with symptomatic left main
      coronary artery stenosis or stenosis of the three main coronary vessels.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 10, 2015</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative CABG adverse events in hospital</measure>
    <time_frame>day of discharge (average 7 to 10 days)</time_frame>
    <description>Incidence of individual postoperative CABG adverse events in hospital. Postoperative CABG adverse events are defined as the sum of the frequency of myocardial infarction, stroke, mortality, renal failure and gastrointestinal bleeding.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of myocardial infarction (MI)</measure>
    <time_frame>until day of discharge (average 7 to 10 days), 30 days and 3 months postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of stroke</measure>
    <time_frame>until day of discharge (average 7 to 10 days), 30 days and 3 months postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>until day of discharge (average 7 to 10 days), 30 days and 3 months postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal bleeding</measure>
    <time_frame>until day of discharge (average 7 to 10 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of renal failure</measure>
    <time_frame>until day of discharge (average 7 to 10 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anastomosis revision rate due to rebleeding</measure>
    <time_frame>until day of discharge (average 7 to 10 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other adverse events (wound infection, angina, reoperation)</measure>
    <time_frame>until 3 months postop</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Repeat Revascularization</measure>
    <time_frame>until 1 and 3 months postop</time_frame>
    <description>Incidence of repeat revascularization leading to CABG or Percutaneous Coronary Intervention (PCI)</description>
  </other_outcome>
  <other_outcome>
    <measure>Handling of the suture material</measure>
    <time_frame>at time of surgery</time_frame>
    <description>Handling of the suture material using a questionnaire containing different dimension and a 5 point assessment level (Likert Scale)</description>
  </other_outcome>
  <other_outcome>
    <measure>Length of the postoperative hospital stay</measure>
    <time_frame>Until discharge (average 7 to 10 days)</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Improvement of Quality of life Score (EQ-5D-5L)</measure>
    <time_frame>3 months postop</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Coronary Heart Disease</condition>
  <condition>Multi Vessel Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>OPTICABG</arm_group_label>
    <description>Patients undergoing a coronary artery bypass graft surgery for the repair of a multi-vessel disease or left main-coronary disease.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary Artery Bypass Graft surgery</intervention_name>
    <arm_group_label>OPTICABG</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        adult patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing an elective primary coronary artery bypass graft surgery (CABG).

          -  On pump or off pump CABG surgery

          -  Age ≥25 years

          -  Written informed consent

        Exclusion Criteria:

          -  Emergency surgery

          -  Insulin dependent Diabetes Mellitus

          -  Acute myocardial infarction with Creatinine Kinase-MB level &gt; 10% of CK and /or ECG
             signs

          -  Known immunodeficiency or immunosuppression

          -  Other combined aortic valve intervention except cardiac valve or mitral valve surgery

          -  Participation or planned participation in another cardiovascular study before study
             follow-up is completed.

          -  Inability to give informed consent due to mental condition, mental retardation, or
             language barrier.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph M Padró, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospitla de la Santa Creu I Sant Pau</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Petra Baumann, Dr.</last_name>
    <phone>+49-7461-95-1646</phone>
    <email>petra.baumann@aesculap.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Robert Bosch KH Stuttgart</name>
      <address>
        <city>Stuttgart</city>
        <zip>70376</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Sacco Hospital</name>
      <address>
        <city>Milano</city>
        <zip>20157</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital de Santa Maria</name>
      <address>
        <city>Lisboa</city>
        <zip>1649-035</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angelo L Nobre, Prof. Dr.</last_name>
      <phone>+35-191-490-6106</phone>
      <email>angelolucasnobre@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Angelo L Nobre, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Javier Gallego, Dr. M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu I Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Portugal</country>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Hawkes AL, Nowak M, Bidstrup B, Speare R. Outcomes of coronary artery bypass graft surgery. Vasc Health Risk Manag. 2006;2(4):477-84. Review.</citation>
    <PMID>17323602</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2015</study_first_submitted>
  <study_first_submitted_qc>September 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2015</study_first_posted>
  <last_update_submitted>January 9, 2018</last_update_submitted>
  <last_update_submitted_qc>January 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CABG</keyword>
  <keyword>Coronary Artery Bypass Grafting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

